These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7661212)

  • 1. Central retinal vein thrombosis associated with resistance to activated protein C.
    Dhôte R; Bachmeyer C; Horellou MH; Toulon P; Christoforov B
    Am J Ophthalmol; 1995 Sep; 120(3):388-9. PubMed ID: 7661212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion.
    Vine AK; Samama MM
    Am J Ophthalmol; 1997 Nov; 124(5):673-6. PubMed ID: 9372721
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
    Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and a healthy control group].
    Faude S; Faude F; Siegemund A; Wiedemann P
    Ophthalmologe; 1999 Sep; 96(9):594-9. PubMed ID: 10501988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal vein occlusion and resistance to activated protein C].
    Scat Y; Morin Y; Morel C; Haut J
    J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.
    Greven CM; Wall AB
    Am J Ophthalmol; 1997 Nov; 124(5):687-9. PubMed ID: 9372725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
    Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
    Larsson J
    Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thrombosis in older people: prevalence of the factor V gene mutation Q506.
    André E; Siguret V; Alhenc-Gelas M; Saint-Jean O; Gaussem P
    J Am Geriatr Soc; 1998 Dec; 46(12):1545-9. PubMed ID: 9848816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
    Spagnolo BV; Nasrallah FP
    Retina; 1998; 18(4):377-8. PubMed ID: 9730185
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
    Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
    Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
    N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinal vein branch occlusion and palsy of the N. abducens in protein S deficiency].
    Holak HM; Holak NH; Holak S; Holak SA; Szymaniec S
    Ophthalmologe; 2005 Mar; 102(3):279-85. PubMed ID: 15138794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
    Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR
    Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to activated protein C caused by a factor V gene mutation.
    Zöller B; Dahlbäck B
    Curr Opin Hematol; 1995 Sep; 2(5):358-64. PubMed ID: 9372020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.